Jay Wunder, M.D., surgeon-in-chief at Mount Sinai Hospital’s Christopher Sharp Centre for Surgery and Oncology in Toronto, Canada / Source: University Health Network/Mount Sinai Hospital

To quote Jay Wunder, M.D., primary investigator for the award-winning study “The Musculoskeletal Tumor Society is probably the smallest specialty group within AAOS [American Academy of Orthopaedic Surgeons] and patients with sarcoma, which this grant is based on, are likely one of the smallest patient populations in all of orthopaedic surgery given the rarity of sarcoma.”

And yet, this small AAOS sub-speciality won the prestigious AAOS Board of Specialty Societies Research Support Fund $100,000 award (which was enhanced by a $10,000 contribution from the Sarcoma Strong Fund within the Musculoskeletal Tumor Society) for their work “Evaluating the Implementation, Utility, and Clinical Importance of the Patient-Reported Outcome Measure Information System (PROMIS) in Sarcoma Patients: A Multi-Centered Prospective Cohort Study.”  


Subscribe to continue reading

  • Unlimited access to our content and archive
  • Exclusive access to our newsletter
  • Join the Conversation! Exclusive access to article comments.